CN104491733A - Application of traditional Chinese medicine preparation in preparation of medicines for treating anemia, deficiency of vital energy and debilitation - Google Patents

Application of traditional Chinese medicine preparation in preparation of medicines for treating anemia, deficiency of vital energy and debilitation Download PDF

Info

Publication number
CN104491733A
CN104491733A CN201410827066.8A CN201410827066A CN104491733A CN 104491733 A CN104491733 A CN 104491733A CN 201410827066 A CN201410827066 A CN 201410827066A CN 104491733 A CN104491733 A CN 104491733A
Authority
CN
China
Prior art keywords
parts
radix
chinese medicine
medicine preparation
portions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410827066.8A
Other languages
Chinese (zh)
Inventor
邓凤桂
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GUANGDONG JUZHICHENG TECHNOLOGY Co Ltd
Original Assignee
GUANGDONG JUZHICHENG TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GUANGDONG JUZHICHENG TECHNOLOGY Co Ltd filed Critical GUANGDONG JUZHICHENG TECHNOLOGY Co Ltd
Priority to CN201410827066.8A priority Critical patent/CN104491733A/en
Publication of CN104491733A publication Critical patent/CN104491733A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725—Ziziphus, e.g. jujube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A61K36/746—Morinda
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/884—Alismataceae (Water-plantain family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/89—Cyperaceae (Sedge family)
    • A61K36/8905—Cyperus (flatsedge)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/894—Dioscoreaceae (Yam family)
    • A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8966—Fritillaria, e.g. checker lily or mission bells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to the field of traditional Chinese medicines, and relates to an application of a traditional Chinese medicine preparation in preparation of medicines for treating anemia, deficiency of vital energy and debilitation. The traditional Chinese medicine preparation comprises the following main raw materials: astragalus membranaceus, rhizoma atractylodis macrocephalae, ginseng, Chinese yam, radix rehmanniae preparata, morinda officinalis, white peony root, curcuma aromatic, rhizoma cyperi, fritillaria, pericarpium citri reticulatae, cassia twig, salviae miltiorrhizae, poria cocos, paeonia suffruticosa, wolfberries, jujubes, rhizoma alismatis, liquorice and the like. The traditional Chinese medicine preparation has the technical advantages of good effect and the like on treatment of anemia, deficiency of vital energy and debilitation, is capable of treating both symptoms and root causes, focusing on nursing and nourishing, and is simple and feasible in preparation process, stable in medicine effect, wide in application range, free of toxic or side effect, and easy to popularize and apply.

Description

A kind of Chinese medicine preparation is for the preparation of the purposes in treatment anemia, the weak medicine of the deficiency of vital energy
Technical field
The invention belongs to the field of Chinese medicines, relate to a kind of Chinese medicine preparation for the preparation of the purposes in treatment anemia, the weak medicine of the deficiency of vital energy.
Background technology
The traditional Chinese medical science will have a delicate constitution and claim body empty, claim deficiency syndrome, and weakness is divided into the deficiency of vital energy, blood deficiency, the deficiency of YIN, yang deficiency Four types the weakness of chronic disease, in conjunction with the heart, liver, spleen, lung, kidney the five internal organs, then each dirty type having again gas, blood, yin, yang weakness, as insufficiency of lung-QI, deficiency of spleen-YANG etc., theory of Chinese medical science says balance, as long as energy and blood of human body equilibrium between yin and yang, is exactly healthy, unfortunately weak, need take a tonic or nourishing food to build up one's health, unnecessary is pathogenic factor, dispel, reach new balance with it, recover healthy.
The traditional Chinese medical science is thought, " all blood all belongs to the heart ", " middle Jiao is bullied extracting juice, change and red be meaning blood ", " source of blood is kidney, and vital essence is sufficient, and hundred normal pulse are smooth ".As can be seen here, the generating resource of blood is in essence-QI from water and grain, and people absorbs water paddy nutrient substance, absorbs the precise and tiny of ingesta, by gasification, become ying-qi by middle Jiao (taste).Spleen obtain heart-fire a surname fall help, be converted into essence, body fluid, a part for essence is stored in kidney, and to treat the use of biochemistry, another part obtains helping of heart-fire and is converted into blood, with the flourish buffings vital organs of the human body.In kidney, congenital essence obtains the essence-QI from water and grain day after tomorrow, absorbs the transpiration of life fire, is converted into marrow.Marrow obtains that the part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels is burning hot ly to swash, and is divided into the seminal fluid of marrow, and seminal fluid is converted into blood for a surname of life fire steams again, defeated in body, thinks the use of physiology.
The generation of blood and regulate with the Zang-Fu relationship such as the heart, liver,spleen,kidney close, therefore the traditional Chinese medical science calls " the main blood of the heart, blood stored in the liver, the spleen governs the blood." and giving full play to of these functions, depend on again the fiery Wen Zhao of life of kidney.Therefore, the heart, liver,spleen,kidney function are weak, all can cause blood deficiency.And the formation of blood deficiency is nothing more than internal and external factor.Exopathogen six climate exopathogens and warm intrusion body, dive and irregularly go out, and deeply changes the machine of blood, cause fresh blood without life, this paathogenic factor and modern medicine said " bacteriological infection, protozoon, toxin generation haemolysis are disease " perfectly in harmony.In endogenous cause of ill, or forfeit one's integrity for seven emotions, or be improper diet, or form for losing blood, or be that natural endowment is not enough, or exaggerate for exhaustion due to sexual indulgence after being ill, or be pregnant imbalance, and cause the machine of hemopoietic to be obstructed; Or the machine of digestion is disorderly, indigestion, does not precise and tinyly become, and the disease of blood deficiency occurs.Visible in endogenous cause of ill with modern medicine said " lack hemopoietic raw material or hemopoietic organ's dysfunction, or chronic blood loss forming anemia " be consistent substantially.
Blood is tangible thing, and gas belongs to invisible use.The operation of blood depends on gas, thus have " qi being the governor of blood, the capable then blood of gas, blood being the material foundation of QI, blood to gas also to " theory.Blood is given birth to by gas, and gas also must have blood for depending on, its effect that is biochemical, motion of competence exertion.The two interdepends, and promotes mutually again, keeps relative equilibrium.If qi-blood disharmony, will cause a disease."Nei Jing" is said: " be therefore excess of QI leading to insufficiency of blood that the institute of blood is also the deficiency of vital energy." therefore, blood deficiency patient generally all has the deficiency of vital energy, this on Diagnosis and Treat all tool have very important significance.
Summary of the invention
The technical problem to be solved in the present invention is to provide a kind of Chinese medicine preparation for the preparation for the treatment of anemia, purposes in the weak medicine of the deficiency of vital energy, and described Chinese medicine preparation can utilize modern pharmaceutical technology to make to facilitate easy-to-use finished product preparation.
For solving this technical problem, inventor is according to self experience of practising medicine for many years, treat on the basis of the weak experience of anemia, the deficiency of vital energy summing up ancients, in conjunction with modern industry pharmaceutical technology feature, again composition of prescription, Clinical Practice replication and adjustment, invented one finally to anemia, weak brand-new Chinese prescription and its preparation technology having remarkable therapeutic effect of the deficiency of vital energy.This Chinese prescription is (with parts by weight):
Radix Astragali 13-37 part, Rhizoma Atractylodis Macrocephalae 17-31 part, Radix Ginseng 18-32 part, RHIIZOMA DIOSCOREAE fr0m Henan of China 17-33 part, Radix Rehmanniae Preparata 10-26 part, Radix Morindae Officinalis 6-24 part, Radix Paeoniae Alba 7-21 part, Radix Curcumae 6-18 part, Rhizoma Cyperi 5-17 part, Bulbus Fritillariae Cirrhosae 6-18 part, Pericarpium Citri Reticulatae 11-25 part, Ramulus Cinnamomi 8-24 part, Radix Salviae Miltiorrhizae 10-24 part, Poria 6-18 part, Cortex Moutan 6-18 part, Fructus Lycii 5-17 part, Fructus Jujubae 7-23 part, Rhizoma Alismatis 5-15 part, Radix Glycyrrhizae 8-18 part.
Three proportionings optimized are respectively:
1, the Radix Astragali 30 parts, the Rhizoma Atractylodis Macrocephalae 24 parts, Radix Ginseng 25 parts, RHIIZOMA DIOSCOREAE fr0m Henan of China 25 parts, 18 parts, Radix Rehmanniae Preparata, Radix Morindae Officinalis 15 parts, the Radix Paeoniae Alba 14 parts, Radix Curcumae 12 parts, Rhizoma Cyperi 11 parts, Bulbus Fritillariae Cirrhosae 12 parts, Pericarpium Citri Reticulatae 18 parts, Ramulus Cinnamomi 16 parts, Radix Salviae Miltiorrhizae 17 parts, 12 parts, Poria, Cortex Moutan 12 parts, Fructus Lycii 11 parts, 15 parts, Fructus Jujubae, Rhizoma Alismatis 10 parts, 13 parts, Radix Glycyrrhizae.
2, the Radix Astragali 32 parts, the Rhizoma Atractylodis Macrocephalae 25 parts, Radix Ginseng 23 parts, RHIIZOMA DIOSCOREAE fr0m Henan of China 24 parts, 19 parts, Radix Rehmanniae Preparata, Radix Morindae Officinalis 16 parts, the Radix Paeoniae Alba 13 parts, Radix Curcumae 13 parts, Rhizoma Cyperi 10 parts, Bulbus Fritillariae Cirrhosae 13 parts, Pericarpium Citri Reticulatae 19 parts, Ramulus Cinnamomi 15 parts, Radix Salviae Miltiorrhizae 18 parts, 11 parts, Poria, Cortex Moutan 14 parts, Fructus Lycii 10 parts, 16 parts, Fructus Jujubae, Rhizoma Alismatis 11 parts, 14 parts, Radix Glycyrrhizae.
3, the Radix Astragali 31 parts, the Rhizoma Atractylodis Macrocephalae 23 parts, Radix Ginseng 24 parts, RHIIZOMA DIOSCOREAE fr0m Henan of China 26 parts, 19 parts, Radix Rehmanniae Preparata, Radix Morindae Officinalis 17 parts, the Radix Paeoniae Alba 15 parts, Radix Curcumae 11 parts, Rhizoma Cyperi 12 parts, Bulbus Fritillariae Cirrhosae 14 parts, Pericarpium Citri Reticulatae 16 parts, Ramulus Cinnamomi 18 parts, Radix Salviae Miltiorrhizae 18 parts, 11 parts, Poria, Cortex Moutan 14 parts, Fructus Lycii 12 parts, 14 parts, Fructus Jujubae, Rhizoma Alismatis 11 parts, 14 parts, Radix Glycyrrhizae.
The preparation technology above-mentioned Chinese prescription being made finished product preparation is following steps:
(1), the ingredientss such as the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Radix Ginseng, RHIIZOMA DIOSCOREAE fr0m Henan of China, Radix Rehmanniae Preparata, Radix Morindae Officinalis, the Radix Paeoniae Alba, Radix Curcumae, Rhizoma Cyperi, Bulbus Fritillariae Cirrhosae, Pericarpium Citri Reticulatae, Ramulus Cinnamomi, Radix Salviae Miltiorrhizae, Poria, Cortex Moutan, Fructus Lycii, Fructus Jujubae, Rhizoma Alismatis, Radix Glycyrrhizae are taken respectively by Chinese prescription, pulverize respectively, for subsequent use;
(2), all medical materials are added the purified water of initial medical material 8-12 times weight, soak 12-24 hour, backflow decocts 1-3 hour, filter, add the purified water of initial weight 5-9 times weight again, backflow decocts 1-3 hour, filters and retains filtering residue, merging filtrate, being concentrated into 55 DEG C of-60 DEG C of relative densities is that the concentrated solution of 1.20-1.25 is for subsequent use;
(3), the filtering residue of step (2) is added the ethanol of the concentration 65-80% of 5-7 times of weight, reflux, extract, 2 times, each 2-5 hour, filter, merging filtrate, distilling under reduced pressure removing ethanol, and to be concentrated into 55 DEG C of-60 DEG C of relative densities be that the concentrated solution of 1.20-1.25 is for subsequent use;
(4), by the concentrated solution of step (2) and (3) gained merge, continuing to be concentrated into 55 DEG C of-60 DEG C of relative densities is the Chinese medical concrete of 1.33-1.38, for subsequent use;
(5), by the Chinese medical concrete of step (4) add suitable adjuvant, utilize modern general Chinese medicine preparation technology to make the finished product preparation of clinical needs, as dosage forms such as capsule, granule, tablet, pill, powder, syrup or oral liquids.
Source, the nature and flavor of Chinese medicine preparation of the present invention Chinese crude drug used, return through and effect:
The Radix Astragali: this product is the dry root of leguminous plant Radix Astagali or Radix Astragali.Sweet in the mouth, warm in nature; Return lung, spleen channel; Invigorating QI to consolidate the body surface resistance, diuresis poison holding, evacuation of pus, expelling pus and promoting granulation.
The Rhizoma Atractylodis Macrocephalae: this product is the dry rhizome of the feverfew Rhizoma Atractylodis Macrocephalae.Bitter in the mouth, sweet, warm in nature; Return spleen, stomach warp; Invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis, antiabortive.
Radix Ginseng: this product is the dry root of Araliaceae Radix Ginseng.Sweet in the mouth, micro-hardship, property is put down; Return spleen, lung, heart channel; Strongly invigorating primordial QI, multiple arteries and veins takes off admittedly, and invigorating the spleen to benefit the lung, promotes the production of body fluid, and calms the nerves.
RHIIZOMA DIOSCOREAE fr0m Henan of China: this product is the dry rhizome of Dioscoreaceae plant Rhizoma Dioscoreae.Sweet in the mouth, property is put down; Return spleen, lung, kidney channel; Spleen reinforcing nourishing the stomach, promote the production of body fluid lung benefiting, the kidney invigorating arresting seminal emission.
Radix Rehmanniae Preparata: this product is the Preparation process product of Radix Rehmanniae.Sweet in the mouth, slightly warm in nature; Return liver, kidney channel; Nourishing YIN and supplementing blood, beneficial essence fills out marrow.
Radix Morindae Officinalis: this product is dicotyledon Rubiaceae radix Morindae Officinalisdry root.Acrid in the mouth, sweet, warm in nature; Warming and recuperating the kidney-YANG, dispels cold-damp.
The Radix Paeoniae Alba: this product is the dry root of ranunculaceae plant Radix Paeoniae.Bitter in the mouth, acid, cold nature; Return liver, spleen channel; Suppressing the hyperactive liver pain relieving, nourishing blood for regulating menstruation, astringing YIN to stop sweating.
Radix Curcumae: this product is the tuber of zingiberaceous plant Rhizoma Curcumae Longae, Radix Curcumae or Rhizoma Curcumae.Acrid in the mouth, hardship, cold in nature; Return liver, lung, pericardium channel; Only invigorate blood circulation can, promoting QI circulation for relieving depression, depressed liver-energy dispersing and function of gallbladder promoting.
Rhizoma Cyperi: this product is the dry rhizome of sedge dried tuber.Acrid in the mouth, micro-hardship, micro-sweet, property is put down; Return liver, spleen, tri-jiao channel; Promoting QI circulation for relieving depression, menstruction regulating and pain relieving.
Bulbus Fritillariae Cirrhosae: this product is the dry bulb of liliaceous plant Bulbus Fritillariae Cirrhosae, Fritillaria unibracteata, Gansu Bulbus Fritillariae Uninbracteatae or Bulbus Fritillariae cirrhosae.Bitter in the mouth, sweet, cold nature; Return lung, heart channel; Clearing heat and moistening lung, preventing phlegm from forming and stopping coughing.
Pericarpium Citri Reticulatae: be the mature peel of rutaceae orange and variety thereof.Bitter in the mouth, pungent, warm in nature; Return lung, spleen channel; Regulating qi-flowing for strengthening spleen, drying dampness to eliminate phlegm.
Ramulus Cinnamomi: this product is the dry twig of canella Cortex Cinnamomi.Acrid in the mouth, sweet, warm in nature; GUIXIN, lung, urinary bladder channel; Diaphoresis expelling pathogenic factors from muscles, promoting the flow of QI-blood by warming the meridian, supporing yang activating QI, the flat gas that spins.
Radix Salviae Miltiorrhizae: this product is dicotyledon Labiatae salviathe dry root of Radix Salviae Miltiorrhizae.Bitter in the mouth, cold nature; Return liver, spleen channel; Blood circulation promoting and blood stasis dispelling, menstruction regulating and pain relieving, calming heart and tranquilizing mind.
Poria: this product is the dry sclerotia of On Polyporaceae Poria.Sweet in the mouth, light, property is put down; GUIXIN, spleen, kidney channel; Eliminating dampness and diuresis, invigorating the spleen and regulating the stomach, mind tranquilizing and the heart calming.
Cortex Moutan: this product is the dry root bark of ranunculaceae peony.Bitter in the mouth, pungent, cold nature; GUIXIN, liver, kidney channel; Clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling.
Fructus Lycii: this product is the dry mature fruit of plant of Solanaceae lycium barbarum.Sweet in the mouth, property is put down; Return liver, kidney channel; Nourishing the liver and kidney, replenishing vital essence to improve eyesight.
Fructus Jujubae: this product is the dry mature fruit of Rhamnaceae jujube Fructus Jujubae.Sweet in the mouth, warm in nature; Return spleen, stomach warp; Invigorating the spleen and replenishing QI, nourishing blood to tranquillize the mind.
Rhizoma Alismatis: this product is the dry tuber of Notes On Alism At Aceae Rhizoma Alismatis.Sweet in the mouth, cold in nature; Return kidney, urinary bladder channel; Diuresis, clearing away damp-heat.
Radix Glycyrrhizae: this product is the dry root of glycyrrhizic legume, Glycyrrhiza inflata Bat. or Glycyrrhiza glabra L..Sweet in the mouth, property is put down; GUIXIN, lung, spleen, stomach warp; Invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.
The prescription analysis of Chinese prescription of the present invention:
Chinese prescription of the present invention is with the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Radix Ginseng, RHIIZOMA DIOSCOREAE fr0m Henan of China, Radix Rehmanniae Preparata for monarch drug, invigorating QI to consolidate the body surface resistance, invigorating the spleen and benefiting QI, invigorating the spleen to benefit the lung, nourishing YIN and supplementing blood; With Radix Morindae Officinalis, Pericarpium Citri Reticulatae, Ramulus Cinnamomi, Radix Salviae Miltiorrhizae, Fructus Jujubae for ministerial drug, supplementing QI for promoting the production of body fluid, regulating qi-flowing for strengthening spleen, promoting the flow of QI-blood by warming the meridian, enrich blood invigorate blood circulation, nourishing blood to tranquillize the mind; With the Radix Paeoniae Alba, Poria, Bulbus Fritillariae Cirrhosae, Cortex Moutan for adjuvant drug, nourishing blood for regulating menstruation, eliminating dampness and diuresis, clearing heat and moistening lung, blood circulation promoting and blood stasis dispelling; With Radix Curcumae, Rhizoma Cyperi, Fructus Lycii, Rhizoma Alismatis for making medicine, blood-activating and qi-promoting, promoting QI circulation for relieving depression, nourishing the liver and kidney, clearing away heat and promoting diuresis; With Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription, make all medicine coordinated, complement each other, jointly reach the effects such as invigorating QI to consolidate the body surface resistance, nourishing YIN and supplementing blood, regulating qi-flowing for strengthening spleen, nourishing blood for regulating menstruation, to anemia, the deficiency of vital energy be weak etc., disease has very significant therapeutic effect.
Compared with prior art, Chinese medicine preparation of the present invention has effective, treating both the principal and secondary aspects of a disease, stresses the technical advantages such as conditioning nourishing in treatment anemia, the deficiency of vital energy are weak, and its preparation process is simple and easy to do, preparation efficacy stability, applied widely, without any side effects, be easy to apply.
Detailed description of the invention
Embodiment 1
Capsule preparations is produced by the numerical value of the optimum ratio 1 of Chinese prescription of the present invention:
(1), Radix Astragali 3000g, Rhizoma Atractylodis Macrocephalae 2400g, Radix Ginseng 2500g, RHIIZOMA DIOSCOREAE fr0m Henan of China 2500g, Radix Rehmanniae Preparata 1800g, Radix Morindae Officinalis 1500g, Radix Paeoniae Alba 1400g, Radix Curcumae 1200g, Rhizoma Cyperi 1100g, Bulbus Fritillariae Cirrhosae 1200g, Pericarpium Citri Reticulatae 1800g, Ramulus Cinnamomi 1600g, Radix Salviae Miltiorrhizae 1700g, Poria 1200g, Cortex Moutan 1200g, Fructus Lycii 1100g, Fructus Jujubae 1500g, Rhizoma Alismatis 1000g, Radix Glycyrrhizae 1300g is taken respectively by Chinese prescription, pulverize respectively, for subsequent use;
(2), all medical materials are added the purified water of initial medical material 11 times of weight, soak 16 hours, backflow decoction 2 hours, filter, add the purified water of initial weight 7 times of weight again, backflow decoction 2 hours, filters and retains filtering residue, merging filtrate, being concentrated into 55 DEG C of-60 DEG C of relative densities is that the concentrated solution of 1.20-1.25 is for subsequent use;
(3), the filtering residue of step (2) is added the ethanol of the concentration 75% of 6 times of weight, reflux, extract, 2 times, each 3 hours, filter, merging filtrate, distilling under reduced pressure removing ethanol, and to be concentrated into 55 DEG C of-60 DEG C of relative densities be that the concentrated solution of 1.20-1.25 is for subsequent use;
(4), by the concentrated solution of step (2) and (3) gained merge, continuing to be concentrated into 55 DEG C of-60 DEG C of relative densities is the Chinese medical concrete of 1.33-1.38, for subsequent use;
(5), by the Chinese medical concrete of step (4) add suitable adjuvant, utilize modern general Chinese medicine preparation technology to make capsule, amounting to crude drug content is 0.96g crude drug/capsules.
Embodiment 2
Capsule preparations is produced by the numerical value of the optimum ratio 2 of Chinese prescription of the present invention:
(1), Radix Astragali 3200g, Rhizoma Atractylodis Macrocephalae 2500g, Radix Ginseng 2300g, RHIIZOMA DIOSCOREAE fr0m Henan of China 2400g, Radix Rehmanniae Preparata 1900g, Radix Morindae Officinalis 1600g, Radix Paeoniae Alba 1300g, Radix Curcumae 1300g, Rhizoma Cyperi 1000g, Bulbus Fritillariae Cirrhosae 1300g, Pericarpium Citri Reticulatae 1900g, Ramulus Cinnamomi 1500g, Radix Salviae Miltiorrhizae 1800g, Poria 1100g, Cortex Moutan 1400g, Fructus Lycii 1000g, Fructus Jujubae 1600g, Rhizoma Alismatis 1100g, Radix Glycyrrhizae 1400g is taken respectively by Chinese prescription, pulverize respectively, for subsequent use;
(2), all medical materials are added the purified water of initial medical material 11 times of weight, soak 16 hours, backflow decoction 2 hours, filter, add the purified water of initial weight 7 times of weight again, backflow decoction 2 hours, filters and retains filtering residue, merging filtrate, being concentrated into 55 DEG C of-60 DEG C of relative densities is that the concentrated solution of 1.20-1.25 is for subsequent use;
(3), the filtering residue of step (2) is added the ethanol of the concentration 75% of 6 times of weight, reflux, extract, 2 times, each 3 hours, filter, merging filtrate, distilling under reduced pressure removing ethanol, and to be concentrated into 55 DEG C of-60 DEG C of relative densities be that the concentrated solution of 1.20-1.25 is for subsequent use;
(4), by the concentrated solution of step (2) and (3) gained merge, continuing to be concentrated into 55 DEG C of-60 DEG C of relative densities is the Chinese medical concrete of 1.33-1.38, for subsequent use;
(5), by the Chinese medical concrete of step (4) add suitable adjuvant, utilize modern general Chinese medicine preparation technology to make capsule, amounting to crude drug content is 0.96g crude drug/capsules.
Embodiment 3
Capsule preparations is produced by the numerical value of the optimum ratio 3 of Chinese prescription of the present invention:
(1), Radix Astragali 3100g, Rhizoma Atractylodis Macrocephalae 2300g, Radix Ginseng 2400g, RHIIZOMA DIOSCOREAE fr0m Henan of China 2600g, Radix Rehmanniae Preparata 1900g, Radix Morindae Officinalis 1700g, Radix Paeoniae Alba 1500g, Radix Curcumae 1100g, Rhizoma Cyperi 1200g, Bulbus Fritillariae Cirrhosae 1400g, Pericarpium Citri Reticulatae 1600g, Ramulus Cinnamomi 1800g, Radix Salviae Miltiorrhizae 1800g, Poria 1100g, Cortex Moutan 1400g, Fructus Lycii 1200g, Fructus Jujubae 1400g, Rhizoma Alismatis 1100g, Radix Glycyrrhizae 1400g is taken respectively by Chinese prescription, pulverize respectively, for subsequent use;
(2), all medical materials are added the purified water of initial medical material 11 times of weight, soak 16 hours, backflow decoction 2 hours, filter, add the purified water of initial weight 7 times of weight again, backflow decoction 2 hours, filters and retains filtering residue, merging filtrate, being concentrated into 55 DEG C of-60 DEG C of relative densities is that the concentrated solution of 1.20-1.25 is for subsequent use;
(3), the filtering residue of step (2) is added the ethanol of the concentration 75% of 6 times of weight, reflux, extract, 2 times, each 3 hours, filter, merging filtrate, distilling under reduced pressure removing ethanol, and to be concentrated into 55 DEG C of-60 DEG C of relative densities be that the concentrated solution of 1.20-1.25 is for subsequent use;
(4), by the concentrated solution of step (2) and (3) gained merge, continuing to be concentrated into 55 DEG C of-60 DEG C of relative densities is the Chinese medical concrete of 1.33-1.38, for subsequent use;
(5), by the Chinese medical concrete of step (4) add suitable adjuvant, utilize modern general Chinese medicine preparation technology to make capsule, amounting to crude drug content is 0.96g crude drug/capsules.
Embodiment 4
Capsule preparations is produced by the minimum value of Chinese prescription scope of the present invention:
(1), Radix Astragali 1400g, Rhizoma Atractylodis Macrocephalae 1800g, Radix Ginseng 1900g, RHIIZOMA DIOSCOREAE fr0m Henan of China 1800g, Radix Rehmanniae Preparata 1100g, Radix Morindae Officinalis 700g, Radix Paeoniae Alba 800g, Radix Curcumae 700g, Rhizoma Cyperi 600g, Bulbus Fritillariae Cirrhosae 700g, Pericarpium Citri Reticulatae 1200g, Ramulus Cinnamomi 900g, Radix Salviae Miltiorrhizae 1100g, Poria 700g, Cortex Moutan 700g, Fructus Lycii 600g, Fructus Jujubae 800g, Rhizoma Alismatis 600g, Radix Glycyrrhizae 900g is taken respectively by Chinese prescription, pulverize respectively, for subsequent use;
(2), all medical materials are added the purified water of initial medical material 11 times of weight, soak 16 hours, backflow decoction 2 hours, filter, add the purified water of initial weight 7 times of weight again, backflow decoction 2 hours, filters and retains filtering residue, merging filtrate, being concentrated into 55 DEG C of-60 DEG C of relative densities is that the concentrated solution of 1.20-1.25 is for subsequent use;
(3), the filtering residue of step (2) is added the ethanol of the concentration 75% of 6 times of weight, reflux, extract, 2 times, each 3 hours, filter, merging filtrate, distilling under reduced pressure removing ethanol, and to be concentrated into 55 DEG C of-60 DEG C of relative densities be that the concentrated solution of 1.20-1.25 is for subsequent use;
(4), by the concentrated solution of step (2) and (3) gained merge, continuing to be concentrated into 55 DEG C of-60 DEG C of relative densities is the Chinese medical concrete of 1.33-1.38, for subsequent use;
(5), by the Chinese medical concrete of step (4) add suitable adjuvant, utilize modern general Chinese medicine preparation technology to make capsule, amounting to crude drug content is 0.96g crude drug/capsules.
Embodiment 5
Capsule preparations is produced by the greatest measure of Chinese prescription scope of the present invention:
(1), Radix Astragali 3600g, Rhizoma Atractylodis Macrocephalae 3000g, Radix Ginseng 3100g, RHIIZOMA DIOSCOREAE fr0m Henan of China 3200g, Radix Rehmanniae Preparata 2500g, Radix Morindae Officinalis 2300g, Radix Paeoniae Alba 2000g, Radix Curcumae 1700g, Rhizoma Cyperi 1600g, Bulbus Fritillariae Cirrhosae 1700g, Pericarpium Citri Reticulatae 2400g, Ramulus Cinnamomi 2300g, Radix Salviae Miltiorrhizae 2300g, Poria 1700g, Cortex Moutan 1700g, Fructus Lycii 1600g, Fructus Jujubae 2200g, Rhizoma Alismatis 1400g, Radix Glycyrrhizae 1700g is taken respectively by Chinese prescription, pulverize respectively, for subsequent use;
(2), all medical materials are added the purified water of initial medical material 11 times of weight, soak 16 hours, backflow decoction 2 hours, filter, add the purified water of initial weight 7 times of weight again, backflow decoction 2 hours, filters and retains filtering residue, merging filtrate, being concentrated into 55 DEG C of-60 DEG C of relative densities is that the concentrated solution of 1.20-1.25 is for subsequent use;
(3), the filtering residue of step (2) is added the ethanol of the concentration 75% of 6 times of weight, reflux, extract, 2 times, each 3 hours, filter, merging filtrate, distilling under reduced pressure removing ethanol, and to be concentrated into 55 DEG C of-60 DEG C of relative densities be that the concentrated solution of 1.20-1.25 is for subsequent use;
(4), by the concentrated solution of step (2) and (3) gained merge, continuing to be concentrated into 55 DEG C of-60 DEG C of relative densities is the Chinese medical concrete of 1.33-1.38, for subsequent use;
(5), by the Chinese medical concrete of step (4) add suitable adjuvant, utilize modern general Chinese medicine preparation technology to make capsule, amounting to crude drug content is 0.96g crude drug/capsules.
Embodiment 6
Capsule preparations is produced by the arbitrary numerical value within the scope of Chinese prescription of the present invention:
(1), Radix Astragali 1400g, Rhizoma Atractylodis Macrocephalae 3000g, Radix Ginseng 1900g, RHIIZOMA DIOSCOREAE fr0m Henan of China 3200g, Radix Rehmanniae Preparata 1100g, Radix Morindae Officinalis 2300g, Radix Paeoniae Alba 800g, Radix Curcumae 1700g, Rhizoma Cyperi 600g, Bulbus Fritillariae Cirrhosae 1700g, Pericarpium Citri Reticulatae 1200g, Ramulus Cinnamomi 2300g, Radix Salviae Miltiorrhizae 1100g, Poria 1700g, Cortex Moutan 700g, Fructus Lycii 1600g, Fructus Jujubae 800g, Rhizoma Alismatis 1400g, Radix Glycyrrhizae 900g is taken respectively by Chinese prescription, pulverize respectively, for subsequent use;
(2), all medical materials are added the purified water of initial medical material 11 times of weight, soak 16 hours, backflow decoction 2 hours, filter, add the purified water of initial weight 7 times of weight again, backflow decoction 2 hours, filters and retains filtering residue, merging filtrate, being concentrated into 55 DEG C of-60 DEG C of relative densities is that the concentrated solution of 1.20-1.25 is for subsequent use;
(3), the filtering residue of step (2) is added the ethanol of the concentration 75% of 6 times of weight, reflux, extract, 2 times, each 3 hours, filter, merging filtrate, distilling under reduced pressure removing ethanol, and to be concentrated into 55 DEG C of-60 DEG C of relative densities be that the concentrated solution of 1.20-1.25 is for subsequent use;
(4), by the concentrated solution of step (2) and (3) gained merge, continuing to be concentrated into 55 DEG C of-60 DEG C of relative densities is the Chinese medical concrete of 1.33-1.38, for subsequent use;
(5), by the Chinese medical concrete of step (4) add suitable adjuvant, utilize modern general Chinese medicine preparation technology to make capsule, amounting to crude drug content is 1.02g crude drug/capsules.
Embodiment 7
The animal toxicity test of Chinese medicine preparation of the present invention
1, test drug: Chinese medicine capsules obtained by embodiment of the present invention 1-6, abolishes capsule shells, adds purified water and is modulated into magma.
Test animal used: regular grade NIH mice, body weight 22g ± 4g, male and female half and half, female mice is all without pregnant; SD rat, original body mass 222 ± 10g, male and female half and half, female rats is all without pregnant.
2, acute toxicity test
Application mice carries out acute toxicity testing and shows: mouse stomach Chinese medicine oral liquid of the present invention, under 782.6g crude drug/kg dosage, after administration, mice occurs that light activity reduces, 1 hours recovers normal, Continuous Observation 7 days after administration, none dead mouse, and overall health of patients, diet, take the photograph water, urine and body weight increase all normal.Experimental result shows: the maximum dosage-feeding of mouse stomach Chinese medicine capsules of the present invention is 782.6g crude drug/kg/d(LD 50> 782.6g crude drug/kg).Chinese medicine preparation clinical application every day total amount of the present invention is 0.17g crude drug/kg/d; By weighing machine, the dosis tolerata of mouse stomach Chinese medicine preparation of the present invention is 4603.5 times of clinical patient.Point out this medicine acute toxicity extremely low, clinical drug safety.
3, long term toxicity test
Select SD rat, give the Chinese medicine capsules of the present invention of Three doses: 30.6g crude drug/kg, 10.2g crude drug/kg, 3.4g crude drug/kg(per weight dosage is by 20 times of calculating of clinical application amount, and clinical application amount is according to Pharmacopoeia of the People's Republic of China version in 2010).Every day gavage once, continuous 90 days, after last administration 24 hours respectively group live and kill 1/2 animal (male and female half and half), all the other 1/2 animals continue that observations are alive after 2 weeks kills.Duration of test observes outward appearance, general behavior, food ration, the body weight change of animal; Within after administration 90 days, within 2 weeks, carry out the index checking such as hematology's (RBC, HB, reticulocyte, PLT, CT, WBC and classification) and blood biochemical (AST, ALT, ALP, Glu, BUN, Crea, TP, T.BIL, ALB, CHOL), urine biochemistry, organ coefficient, histopathology with drug withdrawal.
Result of the test shows: Chinese medicine preparation of the present invention is good at high, medium and low dosage treated animal general state, and outward appearance sign, behavioral activity, food-intake and body weight increase change all without exception; Three dosage groups and matched group hematological examination, blood biochemical analysis, urine biochemical analysis all in normal range, without significant difference between group; Each group of main organs histopathological examination shows no obvious abnormalities.These parameters drug withdrawal also had no change after 2 weeks.This test dosage is respectively 180,60,20 times of clinical medicine dose, according to result of the test: Chinese medicine preparation of the present invention has no significant effect rat in high, medium and low three dosage (30.6g crude drug/kg, 10.2g crude drug/kg, 3.4g crude drug/kg) administration in continuous 90 days, without clear and definite toxicity target organ and sensitive indicator, convalescent period observation also has no retardance toxic reaction, points out the dose safety of Chinese medicine preparation clinical practice of the present invention very high.
Embodiment 8 the pharmacodynamic experiment of Chinese medicine preparation of the present invention
1, Experimental agents and dosage
The capsule that the embodiment of the present invention 1 is produced, amounting to crude drug content is 1.02g crude drug/capsules, abolish capsule shells, add purified water, be modulated into the magma of high, normal, basic three kinds of meterings: high dose group is 0.85g/kg/d, middle dosage group is 0.425g/kg/d, low dose group is the crude drug of 0.213g/kg/d, is equivalent to respectively and 5,2.5,1.25 of its clinical medicine dose times.Ferrous sulfate group is the ferrous sulfate of 0.27g/kg/d, is equivalent to 2 times of clinical amounts; FUFANG EJIAO JIANG group is the FUFANG EJIAO JIANG of 22ml/kg/d, is equivalent to 2.5 times of clinical amount; GUIPI WAN group is the GUIPI WAN of 7 g/kg/d, is equivalent to 2.5 times of clinical amount; Blank group is the isometric normal saline of gavage; Above dosage all converts by body surface area.
2, laboratory animal and structure model
Kunming mouse, body weight 22 ± 4g, male and female half and half, female mice is all without pregnant.By animal effect experiment conventional method, build Lost blood anemia mouse model, hemolytic hydracetin-induced anemia mice model, hemopoietic deficiency hydracetin-induced anemia mice model.
3, kind is tested
(1), this preparation is on the impact of the Lost blood anemia mice with insufficiency of the spleen factor
Get Lost blood anemia model mice 66, be divided into 6 groups at random, often organize 11, the Chinese medicine magma of 3 high, normal, basic three dosage of test group difference gavage, ferrous sulfate group is gavage ferrous sulfate according to dosage, the isometric normal saline of blank group gavage.
As a result, blank group hemoglobin is tested and is significantly reduced (P ﹤ 0.01) than before experiment on the 8th day, tests and recovers to some extent for the 10th day, but still significantly lower than before experiment (P ﹤ 0.01); Test the 8th day, Chinese medicine preparation high dose group hemoglobin pole of the present invention is significantly higher than blank group (P ﹤ 0.01), and suitable with ferrous sulfate group; In, low dose group hemoglobin is also significantly higher than blank (P ﹤ 0.05); Test the 10th day, high, medium and low 3 dosage group hemoglobin are all significantly higher than blank (P ﹤ 0.01), and are better than ferrous sulfate group (P ﹥ 0.05).
(2), on the impact of hemolytic blood deficiency mice
Get hemolytic model of blood dificiency mice 66, be divided into 6 groups at random, often organize 11, the Chinese medicine magma of 3 high, normal, basic three dosage of test group difference gavage, GUIPI WAN group is gavage GUIPI WAN according to dosage, the isometric normal saline of blank group gavage.
As a result, subcutaneous injection acetylphenylhydrazine (APH) afterwards each treated animal Hemoglobin Value declines all gradually, second time subcutaneous injection acetylphenylhydrazine (APH) afterwards hemoglobin highly significant lower than experiment before level; Along with the prolongation of administration time, each group Hemoglobin Value demonstrates difference gradually, tests the 7th day, and the experimental group hemoglobin of 3 dosage very significantly (P ﹤ 0.01) is higher than blank group, and suitable with GUIPI WAN group; Test the 9th, 10 day each administration group Hemoglobin Value all very significantly higher than blank group, compare with the clinical dosage of identical multiple, low dose group of the present invention has significantly been better than GUIPI WAN (P ﹤ 0.05).
(3), on the impact of hemopoietic deficiency blood deficiency mice
Get hemopoietic deficiency model of blood dificiency mice 66, be divided into 6 groups at random, often organize 11, the Chinese medicine magma of 3 high, normal, basic three dosage of test group difference gavage, FUFANG EJIAO JIANG group is gavage FUFANG EJIAO JIANG according to dosage, the isometric normal saline of blank group gavage.
As a result, through CO 60the blank group mice of irradiating is compared with intact animal, test the 7th and 10 days leukocyte counts reduce very significantly (P ﹤ 0.01), test the 10th day, medullary cell mitotic index and spleen weight reduce (P ﹤ 0.01) all very significantly, and Spleen nodes is high-visible; Test the 7th day, the height of experimental group, middle dosage group leukocyte count very significantly (P ﹤ 0.01) higher than blank group, test the 10th day, high, medium and low dosage group leukocyte higher than blank group (P ﹤ 0.01), shows that the effect of Chinese medicine preparation of the present invention strengthens along with the prolongation of administration time all very significantly; High, middle dosage group bone marrow mitotic index is very significantly higher than blank group (P ﹤ 0.01), and high dose group is also very significantly higher than intact animal (P ﹤ 0.01), each dosage group increases with dosage and effect strengthens, compare with the clinical dosage of identical multiple, middle dosage group a little more than FUFANG EJIAO JIANG, but without statistical significant difference (P ﹥ 0.05).
High, medium and low dosage group Spleen nodes number all very significantly (P ﹤ 0.01) or significantly (P ﹤ 0.05) higher than blank group, and increase with dosage, effect strengthens, show that Chinese medicine preparation of the present invention can obviously promote that pluripotential hemopoietic stem cell is bred, compare with the clinical dosage of identical multiple, middle dosage group a little more than FUFANG EJIAO JIANG, but without statistical significant difference (P ﹥ 0.05).
4, experiment conclusion: on Lost blood anemia mouse model, Chinese medicine preparation of the present invention demonstrates the effect significantly increasing hemoglobin, and its intensity is better than ferrous sulfate.
On hemolytic hydracetin-induced anemia mice model, Chinese medicine preparation of the present invention demonstrates the effect significantly increasing hemoglobin, and its intensity is significantly better than GUIPI WAN.
On hemopoietic deficiency hydracetin-induced anemia mice model, Chinese medicine preparation of the present invention demonstrates significantly increases leukocyte count and medullary cell mitotic index, promote the effect of pluripotential hemopoietic stem cell propagation, its effect increasing leukocyte count is a little more than FUFANG EJIAO JIANG, and it increases medullary cell mitotic index and promotes that the effect of pluripotential hemopoietic stem cell propagation is also a little more than FUFANG EJIAO JIANG.
In a word, shown by the pharmacodynamics test of 3 kinds of models: the effect that Chinese medicine preparation of the present invention has obvious spleen invigorating and enriches blood.
The clinical trial of the clinical Chinese medicine preparation of embodiment 9 the present invention
1, physical data
270 experimenters are collected in this clinical trial altogether, from certain the People's Hospital of city, certain the People's Hospital of city second, certain institute of traditional Chinese medicine of city, wherein man 85, age 29-66 year, female 185, age 21-68 year, all experimenters are divided into 3 groups, often organize 90,3 group case in sex, age, the course of disease etc. through statistical analysis, there is comparability.
2, test drug
The made capsule of embodiment of the present invention 1-3 (making by 3 optimum ratios), amounting to crude drug content is 0.96g crude drug/capsules.
3, test method
3 test group (A group, B group, C group) made capsule of oral embodiment of the present invention 1-3 respectively, every day 2 times, each 53 weeks is a course for the treatment of, treats 3 courses for the treatment of continuously.Record recurrent cases.
4, therapeutic evaluation
Cure: the weak all transference cures of anemia, the deficiency of vital energy, and make a definite diagnosis through doctor and fully recover;
Effective: the weak partial symptoms of anemia, the deficiency of vital energy disappears or takes a turn for the better;
Invalid: the weak all symptoms of anemia, the deficiency of vital energy are without any improvement, even more serious;
Recurrence: healing person again suffers from original disease in 6 months after drug withdrawal.
5, test data statistical analysis
After test all terminates, by as shown in table 1 for test data statistical analysis.
Table 1 test data statistical analysis table
Group Number of cases Cure (rate) Effectively Invalid Total effective rate Recurrence (rate)
A group (embodiment 1) 90 45(50%) 44 1 98.9% 0
B group (embodiment 2) 90 44(48.9%) 46 0 100% 1(2.3%)
C group (embodiment 3) 90 46(51.1%) 44 0 100% 0
6, conclusion (of pressure testing)
Test data shows, and the average cure rate of Chinese medicine preparation of the present invention is 50%, and average total effective rate is up to 99.6%, average relapse rate is only 0.7%, therefore, Chinese medicine preparation of the present invention has very significant technical advantage in treatment anemia, the deficiency of vital energy are weak, obtains beat all technological achievement.

Claims (6)

1. Chinese medicine preparation is for the preparation of the purposes in treatment anemia, the weak medicine of the deficiency of vital energy, and it is characterized in that, described Chinese medicine preparation with parts by weight Chinese prescription is:
Radix Astragali 13-37 part Rhizoma Atractylodis Macrocephalae 17-31 part Radix Ginseng 18-32 part RHIIZOMA DIOSCOREAE fr0m Henan of China 17-33 part
Radix Rehmanniae Preparata 10-26 part Radix Morindae Officinalis 6-24 part Radix Paeoniae Alba 7-21 part Radix Curcumae 6-18 part
Rhizoma Cyperi 5-17 part Bulbus Fritillariae Cirrhosae 6-18 part Pericarpium Citri Reticulatae 11-25 part Ramulus Cinnamomi 8-24 part
Radix Salviae Miltiorrhizae 10-24 part Poria 6-18 part Cortex Moutan 6-18 part Fructus Lycii 5-17 part
Fructus Jujubae 7-23 part Rhizoma Alismatis 5-15 part Radix Glycyrrhizae 8-18 part.
2. purposes according to claim 1, is characterized in that, described Chinese medicine preparation with parts by weight Chinese prescription be:
The Radix Astragali 30 parts of Rhizoma Atractylodis Macrocephalaes 24 parts of Radix Ginsengs 25 parts of RHIIZOMA DIOSCOREAE fr0m Henan of China 25 parts
Radix Rehmanniae Preparata 18 parts of Radix Morindae Officinaliss 15 portions of Radix Paeoniae Albas 14 portions of Radix Curcumaes 12 parts
Rhizoma Cyperi 11 parts of Bulbus Fritillariae Cirrhosaes 12 parts of Pericarpium Citri Reticulataes 18 parts of Ramulus Cinnamomi 16 parts
Radix Salviae Miltiorrhizae 17 parts of Poria 12 parts of Cortex Moutans 12 parts of Fructus Lycii 11 parts
13 parts, Fructus Jujubae 15 portions of Rhizoma Alismatis 10 portions of Radix Glycyrrhizaes.
3. purposes according to claim 1, is characterized in that, described Chinese medicine preparation with parts by weight Chinese prescription is:
The Radix Astragali 32 parts of Rhizoma Atractylodis Macrocephalaes 25 parts of Radix Ginsengs 23 parts of RHIIZOMA DIOSCOREAE fr0m Henan of China 24 parts
Radix Rehmanniae Preparata 19 parts of Radix Morindae Officinaliss 16 portions of Radix Paeoniae Albas 13 portions of Radix Curcumaes 13 parts
Rhizoma Cyperi 10 parts of Bulbus Fritillariae Cirrhosaes 13 parts of Pericarpium Citri Reticulataes 19 parts of Ramulus Cinnamomi 15 parts
Radix Salviae Miltiorrhizae 18 parts of Poria 11 parts of Cortex Moutans 14 parts of Fructus Lycii 10 parts
14 parts, Fructus Jujubae 16 portions of Rhizoma Alismatis 11 portions of Radix Glycyrrhizaes.
4. purposes according to claim 1, is characterized in that, described Chinese medicine preparation with parts by weight Chinese prescription is:
The Radix Astragali 31 parts of Rhizoma Atractylodis Macrocephalaes 23 parts of Radix Ginsengs 24 parts of RHIIZOMA DIOSCOREAE fr0m Henan of China 26 parts
Radix Rehmanniae Preparata 19 parts of Radix Morindae Officinaliss 17 portions of Radix Paeoniae Albas 15 portions of Radix Curcumaes 11 parts
Rhizoma Cyperi 12 parts of Bulbus Fritillariae Cirrhosaes 14 parts of Pericarpium Citri Reticulataes 16 parts of Ramulus Cinnamomi 18 parts
Radix Salviae Miltiorrhizae 18 parts of Poria 11 parts of Cortex Moutans 14 parts of Fructus Lycii 12 parts
14 parts, Fructus Jujubae 14 portions of Rhizoma Alismatis 11 portions of Radix Glycyrrhizaes.
5., according to the arbitrary described purposes of claim 1-4, it is characterized in that, the preparation technology of described Chinese medicine preparation is following steps:
Step (1), take the ingredientss such as the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Radix Ginseng, RHIIZOMA DIOSCOREAE fr0m Henan of China, Radix Rehmanniae Preparata, Radix Morindae Officinalis, the Radix Paeoniae Alba, Radix Curcumae, Rhizoma Cyperi, Bulbus Fritillariae Cirrhosae, Pericarpium Citri Reticulatae, Ramulus Cinnamomi, Radix Salviae Miltiorrhizae, Poria, Cortex Moutan, Fructus Lycii, Fructus Jujubae, Rhizoma Alismatis, Radix Glycyrrhizae respectively by Chinese prescription, pulverize respectively, for subsequent use;
Step (2), all medical materials are added the purified water of initial medical material 8-12 times weight, soak 12-24 hour, backflow decocts 1-3 hour, filter, add the purified water of initial weight 5-9 times weight again, backflow decocts 1-3 hour, filters and retains filtering residue, merging filtrate, being concentrated into 55 DEG C of-60 DEG C of relative densities is that the concentrated solution of 1.20-1.25 is for subsequent use;
Step (3), the filtering residue of step (2) is added the ethanol of the concentration 65-80% of 5-7 times of weight, reflux, extract, 2 times, each 2-5 hour, filter, merging filtrate, distilling under reduced pressure removing ethanol, and to be concentrated into 55 DEG C of-60 DEG C of relative densities be that the concentrated solution of 1.20-1.25 is for subsequent use;
Step (4), merged by the concentrated solution of step (2) and (3) gained, continuing to be concentrated into 55 DEG C of-60 DEG C of relative densities is the Chinese medical concrete of 1.33-1.38, for subsequent use;
Step (5), the Chinese medical concrete of step (4) is added suitable adjuvant, utilize modern general Chinese medicine preparation technology to make the finished product preparation of clinical needs.
6., according to the arbitrary described purposes of claim 1-4, it is characterized in that, described Chinese medicine preparation makes capsule, granule, tablet, pill, powder, syrup or oral liquid.
CN201410827066.8A 2014-12-29 2014-12-29 Application of traditional Chinese medicine preparation in preparation of medicines for treating anemia, deficiency of vital energy and debilitation Pending CN104491733A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410827066.8A CN104491733A (en) 2014-12-29 2014-12-29 Application of traditional Chinese medicine preparation in preparation of medicines for treating anemia, deficiency of vital energy and debilitation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410827066.8A CN104491733A (en) 2014-12-29 2014-12-29 Application of traditional Chinese medicine preparation in preparation of medicines for treating anemia, deficiency of vital energy and debilitation

Publications (1)

Publication Number Publication Date
CN104491733A true CN104491733A (en) 2015-04-08

Family

ID=52933247

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410827066.8A Pending CN104491733A (en) 2014-12-29 2014-12-29 Application of traditional Chinese medicine preparation in preparation of medicines for treating anemia, deficiency of vital energy and debilitation

Country Status (1)

Country Link
CN (1) CN104491733A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104826071A (en) * 2015-05-25 2015-08-12 苗怡文 Traditional Chinese medicine preparation for treating cerebral hemorrhage sequelae and preparation method of traditional Chinese medicine preparation
CN104873918A (en) * 2015-06-26 2015-09-02 苗怡文 Traditional Chinese medicine preparation for treating gastroptosis and preparation method thereof
CN104904801A (en) * 2015-05-21 2015-09-16 安徽友源食品有限公司 Red bean crisp cake and preparation method thereof
CN105169271A (en) * 2015-10-10 2015-12-23 临沂草之美医药科技有限公司 Application of a pharmaceutical composition in the preparation of medicine for treating amenorrhea
CN116858903A (en) * 2023-07-11 2023-10-10 北京中医药大学 Application of active ingredient for activating TAS1R3 receptor in preparation of medicine for improving anemia

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1131028A (en) * 1995-03-11 1996-09-18 高风兰 Nutritious health-care oral liquor
CN101703744A (en) * 2009-11-18 2010-05-12 泰一和浦(北京)中医药研究院有限公司 Chinese medicinal composition for treating palpitation and shortness of breath and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1131028A (en) * 1995-03-11 1996-09-18 高风兰 Nutritious health-care oral liquor
CN101703744A (en) * 2009-11-18 2010-05-12 泰一和浦(北京)中医药研究院有限公司 Chinese medicinal composition for treating palpitation and shortness of breath and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
肖兴东等: "贫血的中医辨证诊治", 《中国医药指南》 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104904801A (en) * 2015-05-21 2015-09-16 安徽友源食品有限公司 Red bean crisp cake and preparation method thereof
CN104826071A (en) * 2015-05-25 2015-08-12 苗怡文 Traditional Chinese medicine preparation for treating cerebral hemorrhage sequelae and preparation method of traditional Chinese medicine preparation
CN104873918A (en) * 2015-06-26 2015-09-02 苗怡文 Traditional Chinese medicine preparation for treating gastroptosis and preparation method thereof
CN105169271A (en) * 2015-10-10 2015-12-23 临沂草之美医药科技有限公司 Application of a pharmaceutical composition in the preparation of medicine for treating amenorrhea
CN116858903A (en) * 2023-07-11 2023-10-10 北京中医药大学 Application of active ingredient for activating TAS1R3 receptor in preparation of medicine for improving anemia
CN116858903B (en) * 2023-07-11 2026-02-10 北京中医药大学 Application of active ingredients that activate the TAS1R3 receptor in the preparation of drugs to improve anemia

Similar Documents

Publication Publication Date Title
CN104547486A (en) Traditional Chinese medicine preparation for treating anemia and qi-deficiency weakness and preparation process for traditional Chinese medicine preparation
CN104338062A (en) Chinese medicinal preparation for treating stomachache and diarrhea
CN100457176C (en) Chinese medicinal preparation for curriculum of physical and fatigue reducing
CN104491801A (en) Traditional Chinese medicine preparation for treating acute or chronic gastritis and preparation method thereof
CN103263659B (en) Traditional Chinese medicine composition for treating rheumatism bone diseases
CN104491802A (en) Application of traditional Chinese medicine preparation in preparation of medicine for treating acute or chronic gastritis
CN104491672A (en) Traditional Chinese medicine preparation for treating chronic tracheitis and preparation method thereof
CN104491236A (en) Traditional Chinese medicine preparation for treating essential hypertension and preparation method for traditional Chinese medicine preparation
CN104225166A (en) Chinese medicine composition for treating amenorrhea and preparation method thereof
CN104306891A (en) Traditional Chinese medicine for treating neurasthenia
CN105796845A (en) Application of medicine composition in preparing medicine for treating female climacteric syndromes
CN105311470A (en) Application of pharmaceutical composition containing folium artemisiae argyi in preparing medicine for treating diabetic nephropathy
CN104225507A (en) Chinese medicine for treating limb paralysis and pain caused by cerebral hemorrhage
CN104547859A (en) Application of traditional Chinese medicine preparation in preparation of medicine for treating chronic tracheitis
CN104645247B (en) A kind of Chinese medicine preparation for treating hepatolenticular degeneration and preparation method thereof
CN105727089A (en) Application of medicine composition containing folium artemisiae argyi to preparing medicine for treating irritable bowel syndrome
CN104645080A (en) Traditional Chinese medicine preparation for treating dizziness and preparation method of traditional Chinese medicine preparation
CN105456924A (en) Traditional Chinese medicine preparation containing Folium Artemisiae Argyi and having functions of promoting circulation and removing stasis and preparation method thereof
CN105343675A (en) Traditional Chinese medicine preparation for treating adiposis and preparation method thereof
CN104547489A (en) Use of traditional Chinese medicine composition in preparation of medicine for treating comminuted fracture
CN104826076A (en) Traditional Chinese medicine preparation for treating cough during pregnancy and preparation method thereof
CN105770815A (en) Folium artemisiae argyi-containing traditional Chinese medicine composition for treating postpartum collapse and preparation method thereof
CN104800674A (en) Blood replenishing medicine composition and preparing method thereof
CN105688071A (en) Traditional Chinese medicine for treating interstitial lung disease
CN104491602A (en) Traditional Chinese medicine for treating chronic heart failure, premature beat and arrhythmia and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20150408

RJ01 Rejection of invention patent application after publication